|
0
|
|
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
(nature.com)
|
Shitara K
…
Klempner SJ
Nature Medicine
2026-06-01
|
#cancer
#clinical trial
#immunotherapy
#chemotherapy
|
|
0
|
|
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.
(linkinghub.elsevier.com)
|
Degaga TS
…
Thriemer K
Lancet Infectious Diseases
2026-06-01
|
#infection
#malaria
#clinical trial
#drug efficacy
#parasitology
|
|
0
|
|
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
(nature.com)
|
Peng Z
…
Shen L
Nature Medicine
2026-06-01
|
#cancer
#clinical trial
#amplification
#targeted therapy
|
|
0
|
|
SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.
(nature.com)
|
Byers LA
…
Chandana S
Nature Medicine
2026-06-01
|
#cancer
#clinical trial
#immunotherapy
#toxicity
#drug conjugate
|
|
0
|
|
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.
(nature.com)
|
Cho BC
…
Wu YL
Nature Medicine
2026-06-01
|
#cancer
#clinical trial
#immunotherapy
#lung cancer
#ctla-4
|
|
0
|
|
AAV gene therapy for homozygous familial hypercholesterolemia: a phase 1 trial.
(nature.com)
|
Zheng T
…
Wu Y
Nature Medicine
2026-06-01
|
#clinical trial
#gene therapy
#aav
#liver
#hypercholesterolemia
|
|
0
|
|
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.
(nature.com)
|
Grohar PJ
…
Chugh R
Nature Medicine
2026-06-01
|
#cancer
#clinical trial
#chemotherapy
#transcription factor
#ewing sarcoma
|
|
0
|
|
Microbiome research in practice: priorities for clinical translation and impact.
(linkinghub.elsevier.com)
|
Theodosiou AA
…
Jones CE
Clinical Microbiology and Infection
2026-06-01
|
#microbiome
#translation
#metagenomics
#clinical trial
#regulation
|
|
0
|
|
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial.
(linkinghub.elsevier.com)
|
De Coster I
…
Kumar Arora A
Lancet Infectious Diseases
2026-06-01
|
#vaccination
#clinical trial
#immunogenicity
#conjugate
#enteric fever
|
|
0
|
|
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial.
(linkinghub.elsevier.com)
|
Hossain MJ
…
Wierzba TF
Lancet Infectious Diseases
2026-06-01
|
#infection
#vaccination
#clinical trial
#immunogenicity
#diarrhea
|
|
0
|
|
Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial.
(nature.com)
|
Corapi S
…
Cienfuegos S
Nature Medicine
2026-06-01
|
#metabolic
#clinical trial
#pcos
#weight loss
|
|
0
|
|
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.
(nature.com)
|
Ogbogu PU
…
Klion AD
Nature Medicine
2026-06-01
|
#clinical trial
#immunotherapy
#hypereosinophilia
#eosinophil
|